Cargando…
RNAi induced hepatotoxicity results from loss of the first synthesized isoform of miR-122 in mice
Small RNAs can be used to target and eliminate expression of virtually any disease causing gene or infectious virus, resulting in their pre-clinical and clinical development for treating disease(1). To ensure success of RNAi therapeutics, small hairpin RNAs (shRNAs) must co-opt sufficient quantities...
Autores principales: | Valdmanis, Paul N., Gu, Shuo, Chu, Kirk, Jin, Lan, Zhang, Feijie, Munding, Elizabeth M., Zhang, Yue, Huang, Yong, Kutay, Huban, Ghoshal, Kalpana, Lisowski, Leszek, Kay, Mark A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860119/ https://www.ncbi.nlm.nih.gov/pubmed/27064447 http://dx.doi.org/10.1038/nm.4079 |
Ejemplares similares
-
miR-122 removal in the liver activates imprinted microRNAs and enables more effective microRNA-mediated gene repression
por: Valdmanis, Paul N., et al.
Publicado: (2018) -
TGFβ mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3
por: Wang, Bo, et al.
Publicado: (2009) -
Regulation of hepatic glutamine metabolism by miR-122
por: Sengupta, Dipanwita, et al.
Publicado: (2020) -
Role of B Cell Lymphoma 2 in the Regulation of Liver Fibrosis in miR-122 Knockout Mice
por: Teng, Kun-Yu, et al.
Publicado: (2020) -
Weak base pairing in both seed and 3′ regions reduces RNAi off-targets and enhances si/shRNA designs
por: Gu, Shuo, et al.
Publicado: (2014)